AZATHIOPRINE, METHYLPREDNISOLONE, PREDNISONE, AZATHIOPRINE, PREDNISOLONE, RITUXIMAB
APHP211057
Phase 3 small_molecule active
Quick answer
AZATHIOPRINE, METHYLPREDNISOLONE, PREDNISONE, AZATHIOPRINE, PREDNISOLONE, RITUXIMAB for myelin oligodendrocytes glycoprotein antibody associated diseases (MOGAD) is a Phase 3 program (small_molecule) at Pari Pharma GmbH with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Pari Pharma GmbH
- Indication
- myelin oligodendrocytes glycoprotein antibody associated diseases (MOGAD)
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- active